In this post, stem cell tourism means traveling, abroad or within the United States, for stem cell injections sold directly to consumers; its safety depends on the product, the cells and the injector, and regulation differs by country and also within the US. The FDA says unapproved products, “whether recovered from your own body or another person’s body,” “require FDA licensure/approval to be marketed to consumers.” That scope includes your own cells. In Dynamic Stem Cell+, MFAT or BMA from your own body is harvested and injected the same day, with no donor or lab-grown cells, and Aneesh Garg, DO, CAQ performs every PRP and stem cell injection himself, under live ultrasound. We do not call it FDA approved.
If a clinic in Mexico, the Caribbean or another state has sent you a brochure, the trip may be starting to look like the answer. Before you book, read what the research and the FDA say, and take the three questions below to any clinic.
Four things that matter more than the destination
What the research says about the stem cell market
A 2013 review described a large, poorly regulated international market of putative stem cell products, growing despite the absence of randomized clinical trials to support routine use. A 2013 study of clinic websites found that increased scrutiny of stem cell tourism had not had much impact on online claims, which remained overly optimistic. Nor is the market only offshore: between 2014 and 2016, approximately 90 to 100 new US stem cell business websites appeared per year. Before you answer any brochure, read the questions to ask before stem cell therapy.
Reported harms are physical, financial and emotional
A 2022 paper on the direct-to-consumer market names potential physical, economic and emotional harms to patients, and another states that adverse events continue to occur there and that FDA alone cannot adequately address the problem. FDA’s own list of safety concerns includes “Tumor formation”, “Bacterial infections including life-threatening blood infections” and “the therapy not being tested for infectious diseases such as hepatitis and HIV.” In 2016 the New England Journal of Medicine published a case report titled “Glioproliferative Lesion of the Spinal Cord as a Complication of ‘Stem-Cell Tourism’.” Compare the side effects and risks of a same-day procedure.
What the federal rule says, in its own words
The federal rule on human cells and tissues is 21 CFR Part 1271. Section 1271.15(b): “You are not required to comply with the requirements of this part if you are an establishment that removes HCT/P’s from an individual and implants such HCT/P’s into the same individual during the same surgical procedure.” Section 1271.3 lists, among articles “not considered HCT/Ps,” “Minimally manipulated bone marrow for homologous use and not combined with another article.” Neither is an FDA approval of any treatment, ours included, and how these texts apply to a given procedure is a legal question this page does not answer. A 2019 AAOS and NIH consensus recognized “that stem cells have unique characteristics that are not met by minimally manipulated mixed cell preparations,” and recommended “that minimally manipulated cell products be referred to as cell therapy.” We call the service Dynamic Stem Cell+ as a protocol name. More on that: is it really stem cell therapy.
Lab-grown and donor cells, and what FDA’s warning covers
Expanded cells are harvested, then multiplied in a lab; in one published series, fat-derived cells were culture expanded for 3 passages over 3 weeks. Donor cells come from someone else; a 2021 review names birth tissue (umbilical cord, placental membranes, amniotic fluid) as a common allogenic source. FDA’s consumer page goes further. It says “These products require FDA licensure/approval to be marketed to consumers,” and “These unapproved products whether recovered from your own body or another person’s body, include stem cells, stromal vascular fraction (fat-derived cells), umbilical cord blood and/or cord blood stem cells, amniotic fluid, Wharton’s jelly, ortho-biologics, and exosomes.” That scope includes cells from your own body, the category Dynamic Stem Cell+ uses. We do not call Dynamic Stem Cell+ FDA approved.
Who is a candidate here, and who is not
We sort it at the evaluation, with an exam and a review of your imaging.
- A candidate: an active adult with a degenerative or partial-tissue injury who wants a non-surgical option and holds realistic expectations
- A candidate: someone who wants their own tissue, harvested and injected the same day
- Cells are generally not the right tool with an active infection or certain cancers.
- Generally not for a complete structural tear that needs surgical repair
Before you book, ask
- What tissue is in the vial, and whose is it? Your own bone marrow or fat, or a donor or birth-tissue product?
- How is it prepared, and when does it go back in? Concentrated at the point of care and returned the same day, or grown in a lab first?
- Who injects it, under what imaging, and who follows you afterward? A named physician, live ultrasound, and a follow-up plan that does not end at the airport.
What the trip is really for
Nobody books a flight for an injection. You are chasing the ski day, the long trail, the grandkids on your shoulders, and the brochure promised them sooner. That time is worth fighting for. The honest route back starts with knowing what goes into your body, who puts it there, and who will still be your physician when you are home.
Frequently asked questions
Is stem cell tourism safe?
It depends on the product, the cells and the injector, and regulation differs by country and also within the US. Peer-reviewed papers describe a direct-to-consumer market where claims have been found overly optimistic and adverse events continue to occur. FDA’s list of safety concerns with illegally marketed products includes “Tumor formation” and “Cross-contamination with bacteria, viruses or mold related to processing.” Judge any clinic by what is injected, whose cells they are, how they were prepared, who injects them, under what imaging, and who follows you afterward.
Is stem cell treatment in Mexico safe?
It depends on the product, the cells and the injector, and we state the standard rather than grade a nation. A 2022 review describes considerable worldwide variation in the regulatory pathways for orthobiologic therapies, and a 2016 analysis found widespread promotion of unapproved stem cell interventions by businesses based in the United States. A registration is not proof on its own: FDA warns that “the fact that a firm has registered with FDA and listed its product does not mean the product is legally marketed.” Ask any clinic what tissue is in the vial, whose it is, whether it was grown in a lab, who injects it under what imaging, and who follows you after you fly home.
How much are stem cell treatments in Mexico, and which country is cheapest?
We do not publish prices for any clinic, ours included, because a price comparison misses what the price buys. A 2025 review names the dangers of unlicensed stem cell clinics alongside the difficulties patients face in obtaining and paying for care. A brochure price leaves out flights, time away, repeat trips and follow-up. A lower price does not tell you a product was tested. FDA says of unapproved regenerative products, “whether recovered from your own body or another person’s body,” that “Before approval, these products require FDA oversight in a clinical trial.” We give a quote after a thorough evaluation. We price the plan for optimal outcomes, not line items off a menu.
Can stem cells repair dementia?
FDA states that regenerative medicine therapies “have not been approved to treat any neurological disorder,” and its list names Alzheimer’s disease, Parkinson’s disease and stroke. Dynamic Stem Cell+ is offered for certain orthopedic and musculoskeletal conditions. If a clinic, here or abroad, offers stem cells for memory loss, ask which clinical trial under FDA oversight the treatment belongs to, and talk with your neurologist before you book anything.
Is stem cell therapy legal in Colorado?
The federal rule on human cells and tissues is 21 CFR Part 1271. Section 1271.15(b) reads: “You are not required to comply with the requirements of this part if you are an establishment that removes HCT/P’s from an individual and implants such HCT/P’s into the same individual during the same surgical procedure.” Section 1271.3 lists, among articles “not considered HCT/Ps,” “Minimally manipulated bone marrow for homologous use and not combined with another article.” Neither text is an approval, and FDA states that regenerative medicine therapies “have not been approved for the treatment of any orthopedic condition.” How these texts apply to a given procedure is a legal question this page does not answer.
Are donor or umbilical cord stem cells better than my own?
The head-to-head trial evidence does not show it. In the 480-patient MILES trial, a randomized trial published in Nature Medicine, bone marrow aspirate concentrate (BMAC), fat-derived stromal vascular fraction and donor umbilical cord tissue cells were compared with cortisone for knee osteoarthritis, and at 1 year none was superior to another or to cortisone. In the same trial, a secondary responder analysis found a higher VAS responder rate for BMAC than cortisone, driven by male patients; women responded more often to cortisone. A 2025 systematic review found umbilical cord-derived injections had significantly more transient swelling and pain than bone marrow injections.
What should I do if I had a problem after stem cells abroad?
See a physician at home promptly and bring every record you have: what was injected, where, and the clinic’s contact details. If you were hurt or had a bad side effect following treatment with a regenerative medicine product, FDA says, “we also encourage you to report it to the FDA” through its MedWatch Adverse Event Reporting program. FDA also asks you to contact it “if you have been treated with these products and wish to report any adverse effects or file a complaint.” A follow-up plan is one of the questions worth asking before any procedure, anywhere, precisely because the clinic that injected you may be a flight away.
How is Dynamic Stem Cell+ done in Boulder?
With your own tissue, in one visit. Aneesh Garg, DO, CAQ selects MFAT or BMA for the tissue being treated, harvests it, and returns it the same day; when it makes sense he adds FRP and high-dose PRP from a protocol designed to concentrate platelets 12 to 20x baseline (over 10 billion), the system specification. He performs every PRP and stem cell injection himself, under live ultrasound. The procedure, from harvest to injection, is 2 to 3 hours. No donor, umbilical, amniotic or embryonic products are used, and we do not call it FDA approved. Patients’ self-reported results are followed in practice, and separately we run IRB-approved retrospective studies via Rocky Vista University.
Get a straight answer before you book the flight
A clinic abroad means flights, time away and repeat trips. Book the 90-minute appointment with Aneesh Garg, DO, CAQ, usually within the same week, and find out what you can get here.
Book an Evaluation
1790 30th Street Suite 270 · Boulder, CO 80301 · 303-997-1733